| 证券代码 | CDMOP.O |
| 证券名称 | Avid Bioservices Inc Series E Pfd |
| 证券类型 | 美国优先股 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | - |
| 发行方式 | - |
| 首发上市日 | 2014-02-20 |
| 首发价格(元) | - |
| 首发数量(股) | 0 |
| 首发募资额(元) | - |
| 首发主承销商 | - |
| 货币单位 | USD |
| 公司名称 | Avid Bioservices, Inc. |
| 注册地址 | 美国特拉华州 |
| 办公地址 | 2642 Michelle Drive, Suite 200, Tustin, California, USA |
| 成立日期 | 1981-06 |
| 董事会主席 | Joseph Carleone |
| 公司属地 | United States 美国 |
| 公司网址 | www.avidbio.com |
| 电话 | +1 (714) 508-6000 |
| 传真 | - |
| 公司简介 | Avid Bioservices, Inc. is a dedicated contract development and manufacturing organization ( CDMO ) focused on development and cGMP manufacturing of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. |